Literature DB >> 23196758

The risk of lymph node metastasis with positive peritoneal cytology in endometrial cancer.

Gunjal Garg1, Feng Gao, Jason D Wright, Andrea R Hagemann, Israel Zighelboim, David G Mutch, Matthew A Powell.   

Abstract

OBJECTIVE: To determine the correlation between positive peritoneal cytology (PPC) and lymph node metastasis in patients with endometrial cancer grossly confined to the uterus.
METHODS: Data were extracted from the Surveillance, Epidemiology, and End Results database between 1988 and 2005. Only patients with endometrial cancer grossly confined to the uterus who had undergone a complete staging procedure (lymph node removal) were included. Statistical analysis used the χ2 test and logistic regression models.
RESULTS: A total of 22,947 patients were identified. Positive peritoneal cytology was present in 3.5% of the patients. The incidence of lymph node metastasis was significantly higher among patients with PPC compared to those with negative peritoneal cytology for all histologic types examined (P < 0.0001): endometrioid adenocarcinoma, 28.7% versus 6.9%; adenocarcinoma not otherwise specified, 35.4% versus 5.8%; clear cell/serous carcinoma, 41.4% versus 19.0%, and carcinosarcoma,; 38.4% versus 14.4%. After adjusting for other contributing factors in the multivariable model, PPC remained an independent predictor of lymph node metastasis (P < 0.0001).
CONCLUSION: Our data indicate that patients with positive washings are at significant risk of nodal metastasis and adverse prognosis. Although no longer a part of the current International Federation of Gynecology and Obstetrics staging criteria, peritoneal cytology status should continue to inform clinical decision making in endometrial cancer.

Entities:  

Mesh:

Year:  2013        PMID: 23196758      PMCID: PMC3992285          DOI: 10.1097/IGC.0b013e318275afd2

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  25 in total

1.  Re: Systematic pelvic lymphadenectomy vs no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.

Authors:  Stefano Uccella; Karl C Podratz; Giovanni D Aletti; Andrea Mariani
Journal:  J Natl Cancer Inst       Date:  2009-06-09       Impact factor: 13.506

2.  Peritoneal cytology in patients with endometrial carcinoma.

Authors:  M Imachi; N Tsukamoto; T Matsuyama; H Nakano
Journal:  Gynecol Oncol       Date:  1988-05       Impact factor: 5.482

3.  Predictability of retroperitoneal lymph node metastasis by using clinicopathologic variables in surgically staged endometrial cancer.

Authors:  C Taskiran; K Yuce; P O Geyik; T Kucukali; A Ayhan
Journal:  Int J Gynecol Cancer       Date:  2006 May-Jun       Impact factor: 3.437

4.  The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer.

Authors:  Laura J Havrilesky; Janiel M Cragun; Brian Calingaert; Angeles Alvarez Secord; Fidel A Valea; Daniel L Clarke-Pearson; Andrew Berchuck; John T Soper
Journal:  Gynecol Oncol       Date:  2006-10-02       Impact factor: 5.482

5.  Practice patterns of SGO members for stage IIIA endometrial cancer.

Authors:  Christine M Lee; Brian M Slomovitz; Marilyn Greer; Sheena Sharma; Mary Ann Gregurich; Thomas Burke; Karen H Lu; Lois M Ramondetta
Journal:  Gynecol Oncol       Date:  2005-07       Impact factor: 5.482

6.  Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer.

Authors:  Janiel M Cragun; Laura J Havrilesky; Brian Calingaert; Ingrid Synan; Angeles Alvarez Secord; John T Soper; Daniel L Clarke-Pearson; Andrew Berchuck
Journal:  J Clin Oncol       Date:  2005-02-28       Impact factor: 44.544

7.  Predicting pelvic lymph node metastasis in endometrial carcinoma.

Authors:  T Kamura; H Yahata; T Shigematsu; S Ogawa; S Amada; T Kaku; H Nakano
Journal:  Gynecol Oncol       Date:  1999-03       Impact factor: 5.482

8.  Prognostic factors that predict pelvic lymph node metastasis from endometrial carcinoma.

Authors:  B Lampe; R Kürzl; P Hantschmann
Journal:  Cancer       Date:  1994-11-01       Impact factor: 6.860

9.  Prognostic significance of positive peritoneal cytology in endometrial carcinoma confined to the uterus.

Authors:  T Kasamatsu; T Onda; N Katsumata; M Sawada; T Yamada; R Tsunematsu; K Ohmi; Y Sasajima; Y Matsuno
Journal:  Br J Cancer       Date:  2003-01-27       Impact factor: 7.640

10.  Positive peritoneal cytology in early-stage endometrial cancer does not influence prognosis.

Authors:  P-M Tebeu; Y Popowski; H M Verkooijen; C Bouchardy; F Ludicke; M Usel; A L Major
Journal:  Br J Cancer       Date:  2004-08-16       Impact factor: 7.640

View more
  3 in total

1.  Does hysteroscopy worsen prognosis in women with type II endometrial carcinoma?

Authors:  Jiao Chen; Leslie H Clark; Wei-Min Kong; Zhen Yan; Chao Han; Hui Zhao; Ting-Ting Liu; Tong-Qing Zhang; Dan Song; Si-Meng Jiao; Chunxiao Zhou
Journal:  PLoS One       Date:  2017-03-23       Impact factor: 3.240

2.  Revaluating the survival effects of International Federation of Gynecology and Obstetrics 1988 stage IIIA criteria for endometrial cancer.

Authors:  Osman Türkmen; Alper Karalok; Derman Başaran; Günsu Kimyon; Gizem Kul; Gökhan Tulunay; Işın Üreyen; Taner Turan
Journal:  J Turk Ger Gynecol Assoc       Date:  2017-09-01

3.  Diaphragmatic smears are not of additional benefit in the detection of peritoneal spread in gynecological cancers.

Authors:  Celine Montavon; Uzma Mirza; Andre Fedier; Andreas Schoetzau; Rosanna Zanetti Dällenbach; Viola Heinzelmann-Schwarz
Journal:  Exp Ther Med       Date:  2018-03-13       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.